Selenium in the Prevention of Cancer

Summary

This is a pilot study proceeding an intended international trial.

Hypothesis: Daily intake of selenium supplementation in the form of selenium-enriched yeast tablets will reduce the risk of cancer in healthy individuals.

Objective: The objective of this pilot study was to assess the viability of a full scale randomised trial.

AMENDMENT TO STUDY OBJECTIVE: Mortality analysis during intervention and follow-up as specified in the sections concerning study design and outcome measures.

Conditions

• Cancer

Interventions

DIETARY_SUPPLEMENT

SelenoPRECISE selenium-enriched yeast tablet, Pharma Nord Denmark A/S

Sponsors & Collaborators

• Danish Cancer Society

  collaborator OTHER

• University of Southern Denmark

  collaborator OTHER

• K. A. Rohde's and wife's Foundation

  collaborator OTHER

• The County of Funen, Denmark

  collaborator OTHER_GOV

• Cypress Systems, USA

  collaborator UNKNOWN

• The Dagmar Marshall Foundation

  collaborator OTHER

• The N. O. Andersen Foundation

  collaborator UNKNOWN

• The Danish Directory of Food and Agriculture

  collaborator UNKNOWN

• The Foundation of Clinical Experimental Cancer Research, Odense

  collaborator UNKNOWN

• The Foundation of Lily Benthine Lund

  collaborator UNKNOWN

• The Memory Foundation of Merchant Brogaard

  collaborator UNKNOWN

• Pharma Nord

  collaborator INDUSTRY

• Odense University Hospital

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

TRIPLE

Model

PARALLEL

Eligibility

Min Age

60 Years

Max Age

74 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

1998-11-30

Primary Completion

2004-06-30

Completion

2004-06-30

Countries

• Denmark

Study Locations